{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:33:55Z","timestamp":1794346435928,"version":"4.9.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.cgh.2016.07.032","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T14:51:09Z","timestamp":1470927069000},"page":"1806-1812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["No Evidence That Azathioprine Increases Risk of\u00a0Cholangiocarcinoma in Patients With Primary Sclerosing\u00a0Cholangitis"],"prefix":"10.1016","volume":"14","author":[{"given":"Roman","family":"Zenouzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9736-1483","authenticated-orcid":false,"given":"Tobias J.","family":"Weism\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin K.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bubenheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"Lenzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"H\u00fcbener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelius","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Weiler-Normann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcial","family":"Sebode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno","family":"Ehlken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Pannicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Hartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Peiseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"H\u00fcbener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom H.","family":"Karlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten M.","family":"Boberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar W.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2016.07.032_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.07.032_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.07.032_bib3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.07.032_bib4","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3109\/00365529708996522","article-title":"Colorectal dysplasia and carcinoma in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"32","author":"Leidenius","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.07.032_bib5","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.07.032_bib6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrgastro.2014.47","article-title":"Hepatocellular carcinoma: low risk of HCC in patients who have PSC and cirrhosis","volume":"11","author":"Gossard","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2016.07.032_bib7","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.cgh.2014.02.008","article-title":"Low risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis","volume":"12","author":"Zenouzi","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2016.07.032_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.hpb.2015.10.001","article-title":"Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database","volume":"18","author":"Vilchez","year":"2016","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.cgh.2016.07.032_bib9","doi-asserted-by":"crossref","first-page":"15955","DOI":"10.3748\/wjg.v20.i43.15955","article-title":"Histopathology of hepatocellular carcinoma","volume":"20","author":"Schlageter","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.07.032_bib10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bpg.2011.10.002","article-title":"Primary sclerosing cholangitis and malignancy","volume":"25","author":"Boberg","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2016.07.032_bib11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.07.032_bib12","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s10620-006-9681-4","article-title":"Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"52","author":"Fevery","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2016.07.032_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hep.21964","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms","volume":"47","author":"Melum","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.07.032_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bpg.2015.02.003","article-title":"Epidemiology of cholangiocarcinoma","volume":"29","author":"Bergquist","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2016.07.032_bib15","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.510230612","article-title":"Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis","volume":"23","author":"Boberg","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.07.032_bib16","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.07.032_bib17","doi-asserted-by":"crossref","first-page":"943","DOI":"10.7326\/0003-4819-131-12-199912210-00006","article-title":"Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series","volume":"131","author":"Schramm","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2016.07.032_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2036.2010.04330.x","article-title":"Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease","volume":"32","author":"Smith","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2016.07.032_bib19","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.humpath.2014.05.008","article-title":"Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma","volume":"45","author":"Kerr","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cgh.2016.07.032_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAS.0b013e3181bc96f9","article-title":"Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma","volume":"34","author":"Lewis","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cgh.2016.07.032_bib21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.07.032_bib22","series-title":"The statistical analysis of failure time data","first-page":"xi","author":"Kalbfleisch","year":"1980"},{"key":"10.1016\/j.cgh.2016.07.032_bib23","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.07.032_bib24","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jhep.2004.01.002","article-title":"Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy","volume":"40","author":"Brandsaeter","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.07.032_bib25","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2016.07.032_bib26","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2016.07.032_bib27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cgh.2014.05.015","article-title":"Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis","volume":"13","author":"Kotlyar","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2016.07.032_bib28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.510270201","article-title":"Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study","volume":"27","author":"Bergquist","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.07.032_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2796.2001.00775.x","article-title":"Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma","volume":"249","author":"Bergquist","year":"2001","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cgh.2016.07.032_bib30","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00535-011-0519-2","article-title":"Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1","volume":"47","author":"Hino-Arinaga","year":"2012","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2016.07.032_bib31","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/ajg.2009.745","article-title":"Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study","volume":"105","author":"Armstrong","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.07.032_bib32","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1023\/A:1011915032118","article-title":"Unusual development of hepatocellular carcinoma in a patient with Crohn's disease","volume":"46","author":"Borum","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2016.07.032_bib33","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/hupa.2000.7629","article-title":"Hepatocellular carcinoma and focal hepatic glycogenosis after prolonged azathioprine therapy","volume":"31","author":"Cattan","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cgh.2016.07.032_bib34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/gut.2011.237412","article-title":"Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease","volume":"61","author":"van Schaik","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2016.07.032_bib35","doi-asserted-by":"crossref","first-page":"e81487","DOI":"10.1371\/journal.pone.0081487","article-title":"Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: a meta-analysis","volume":"8","author":"Gong","year":"2013","journal-title":"PLoS One"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651630516X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651630516X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:20:08Z","timestamp":1761542408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154235651630516X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S154235651630516X"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2016.07.032","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No Evidence That Azathioprine Increases Risk of\u00a0Cholangiocarcinoma in Patients With Primary Sclerosing\u00a0Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2016.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the AGA Institute","name":"copyright","label":"Copyright"}]}}